Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
30,475,266
-
Share change
-
-1,333,217
-
Total reported value
-
$758,677,656
-
Put/Call ratio
-
75%
-
Price per share
-
$24.90
-
Number of holders
-
94
-
Value change
-
-$4,806,815
-
Number of buys
-
40
-
Number of sells
-
45
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q1 2024
As of 31 Mar 2024,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,475,266 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Deep Track Capital, LP, Paradigm Biocapital Advisors LP, ARMISTICE CAPITAL, LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, MORGAN STANLEY, First Light Asset Management, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Polar Capital Holdings Plc, and SUVRETTA CAPITAL MANAGEMENT, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.